Depression Management at the Workplace (DMW)

This study is currently recruiting participants.
Verified November 2009 by Florida State University
Sponsor:
Collaborator:
Colorado Business Group on Health
Information provided by:
Florida State University
ClinicalTrials.gov Identifier:
NCT01013220
First received: November 12, 2009
Last updated: NA
Last verified: November 2009
History: No changes posted

November 12, 2009
November 12, 2009
January 2009
March 2013   (final data collection date for primary outcome measure)
employer purchase of depression management product [ Time Frame: two years after intervention ] [ Designated as safety issue: No ]
Same as current
No Changes Posted
fidelity of depression management model purchased to evidence-based models [ Time Frame: two years after intervention ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Depression Management at the Workplace
Influencing Employer Purchasing Behavior

Randomized trials demonstrate that depression management products can improve clinical and organizational outcomes sufficiently for selected employers to realize a return on investment. Rather than usual care marketing which uses voltage-enhanced promises to sell voltage-diminished products, the investigators designed an evidence-based (EB) intervention to encourage employers to purchase a depression management product that offers the type, intensity and duration of care shown to provide clinical and organizational value. In an RCT designed to examine employer benefit purchasing behavior of depression products in 360 employer members of over 20 regional business coalitions, the research team proposes: (a) to compare the impact of evidence-based (EB) to usual care (UC) presentations on employer benefit purchasing behavior, and (b) to identify mediators and organizational moderators of intervention impact on employer benefit purchasing behavior.

This study addresses what policy analysts argue is one of the most pivotal problems in the translation of evidence-based care to 'real world' settings: whether purchasers can be influenced to buy health care products on the basis of value rather than cost. In the likely event that EB > UC, the study will provide encouragement to use an evidence-based approach to market new health care products to private payers on the basis of the product's clinical and organizational value. UC may achieve comparable outcomes to EB if the limiting factors in benefit purchasing are organizational, purchasing group and vendor constraints that no intervention can meaningfully modify. Support for this scenario would encourage the targeted marketing of new products to coalition members with empirically identified organizational, purchasing group and vendor characteristics, using usual care strategies.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Health Services Research
Depression
  • Other: Depression Product Detailing
    1. two hour academic detailing of depression management products to employees with responsibility for purchasing health care benefits
    2. technical assistance in purchasing high quality depression management products
  • Other: Depression HEDIS detailing
    1. academic detailing to employees responsible for purchasing health care benefits on how to use HEDIS indicators for depression to assure their depressed employees receive high quality care for the condition
    2. technical assistance
  • Experimental: Depression Product Detailing
    Employers receive education on how to purchase high quality depression management products to improve the quality of depression treatment depressed employees receive. Materials delivered in this arm of the study are available at www.caremanagementfordepression.org
    Intervention: Other: Depression Product Detailing
  • Placebo Comparator: Depression HEDIS Detailing
    Employers receive education on how to obtain and use HEDIS depression indicators to encourage health plans to improve the quality of depression treatment depressed employees receive
    Intervention: Other: Depression HEDIS detailing
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
360
November 2014
March 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Coalitions who belong to the National Business Coalition on Health are eligible if:

    • they have 30+ employer purchasers/affiliates as members
    • they act as more than purchasing agents
    • (3)they did not participate in the research team's preliminary studies on this topic.
  • Employers of participating coalitions are eligible if:

    • they are a public or private organization providing health care benefits to 100+ domestic employees
    • they have not purchased a depression management product in the past two years.

Exclusion Criteria:

  • None
Both
18 Years and older
Yes
Contact: Donna Marshall, MBA 303-922-0939 donna.marshall@cbghealth.org
United States
 
NCT01013220
R01MH76227
No
Kathryn Rost, Florida State University School of Medicine
Florida State University
Colorado Business Group on Health
Principal Investigator: Kathryn Rost, PhD Florida State University College of Medicine
Florida State University
November 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP